Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
Introduction: Mortality associated with invasive group A streptococcal infections (iGAS) remains high among adults, with lower mortality in children. The added value of both clindamycin and immunoglobulins in such treatment is still controversial, as is the need for antibiotic secondary prophylaxis....
Saved in:
Main Authors: | Delphine Laho (Author), Sophie Blumental (Author), Anne Botteaux (Author), Pierre R. Smeesters (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe Staphylococcus aureus infections in children: Case reports and management of positive Panton-Valentine leucocidin cases
by: Sophie Goemanne, et al.
Published: (2022) -
Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe
by: Antoni Soriano-Arandes, et al.
Published: (2023) -
Randomized Clinical Trial of Intrapartum Clindamycin Cream for Reduction of Group B Streptococcal Maternal and Neonatal Colonization
by: R. S. Gibbs, et al.
Published: (1996) -
Instituting CDC Draft Guidelines for Prophylaxis of Neonatal Group B Streptococcal Invasive Disease
by: Marvin S. Amstey
Published: (1995) -
Immunoglobulin-G level on aggressive periodontitis patients treated with clindamycin
by: Agung Krismariono
Published: (2009)